Shanghai Begreat Pharmatech
Records under this name other than the patents Shanghai Begreat Pharmatech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 3 of 3 · Back to Shanghai Begreat Pharmatech
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,352,362 | Polymorph of rucaparib camsylate Lapsed on the fee record Ended Jun 7, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2026 | From the USPTO record |
| US 11,319,293 | Polymorps of cariprazine hydrochloride and preparation method thereof and use of same Lapsed on the fee record Ended May 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2026 | From the USPTO record |
| US 10,544,142 | Crystal forms of palbociclib, and preparation method and use therefor Lapsed on the fee record Ended Jan 28, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 28, 2024 | From the USPTO record |